लेवोथायरोक्सिन और लियोथायरोनिन और नेटेग्लिनाइड का इंटरैक्शन

Insulin or Oral Hypoglycemics — Initiating thyroid replacement therapy may cause increases in insulin or oral hypoglycemic requirements.

Patients receiving insulin or oral hypoglycemics should be closely watched during initiation of thyroid replacement therapy.

Drugs and Herbals That May Reduce the Blood-Glucose-Lowering Effect of Nateglinide and Increase Susceptibility to Hyperglycemia Drugs: Thiazides, corticosteroids, thyroid products, sympathomimetics, somatropin, somatostatin analogues (e.g., lanreotide, octreotide), and CYP inducers (e.g., rifampin, phenytoin and St John's Wort).